Federico P.
- Country
- Italy
- Department
- S.C. Nefrologia - Clinica Nefrologica
Research Overview
- Long-Term Safety and Tolerability Assessment of Dapirolizumab Pegol in Patients with Systemic Lupus Erythematosus: A Multicenter, Open-Label Extension Study
- Evaluation of Dapirolizumab Pegol Efficacy and Safety in Moderately to Severely Active Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Corticosteroids, Dapagliflozin, and RASBs on Proteinuria in IgA Nephropathy Patients with Active and Chronic Renal Lesions
Data & Insights
Has run more than one trial at 89 of 203 partner sites.
Specializations
Glomerular Diseases
This investigator specializes in various forms of glomerulonephritis, with particular expertise in treating IgA nephropathy and membranous nephropathy. Their research encompasses innovative therapeutic approaches for these conditions.
- Primary IgA Nephropathy Management
- Membranous Nephropathy Treatment
- Targeted Therapy Development
Their work includes evaluation of targeted therapies based on kidney biopsy findings and novel therapeutic agents.
Autoimmune Kidney Disorders
The investigator focuses on treating lupus nephritis and related autoimmune kidney conditions. Their expertise extends to evaluating novel biological therapies and complement-targeted treatments.
- Lupus Nephritis Treatment
- Complement Pathway Therapeutics
- Immunological Interventions
Their research includes assessment of innovative biological agents for autoimmune kidney disorders.
Rare Kidney Disorders
The investigator has significant experience in treating focal segmental glomerulosclerosis and evaluating nephroprotective therapies. Their work includes assessment of long-term treatment outcomes.
- FSGS Treatment Strategies
- Novel Therapeutic Agents
- Long-term Disease Management
Their research focuses on developing effective treatments for rare glomerular diseases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.